NEW YORK (GenomeWeb) – German sample preparation firm Scienion and Canadian molecular diagnostics firm Axela today announced they have signed a joint marketing and development agreement to create and sell production systems and services for diagnostic and research products.

"This will provide commercialization partners with an integrated and scalable offering to address emerging diagnostic markets," including oncology, allergy, infectious disease, and other markets, the firms said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.